283 related articles for article (PubMed ID: 9004051)
1. Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors.
Sheline Y; Bardgett ME; Csernansky JG
J Clin Psychopharmacol; 1997 Feb; 17(1):11-4. PubMed ID: 9004051
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
De Bellis MD; Geracioti TD; Altemus M; Kling MA
Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):636-41. PubMed ID: 7687151
[TBL] [Abstract][Full Text] [Related]
3. The effect of paroxetine on cerebrospinal fluid concentrations of neurotransmitter metabolites in depressed patients.
Lundmark J; Wålinder J; Alling C; Manniche PM; Dalgaard L
Eur Neuropsychopharmacol; 1994 Mar; 4(1):1-6. PubMed ID: 7515737
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid.
Mårtensson B; Nyberg S; Toresson G; Brodin E; Bertilsson L
Acta Psychiatr Scand; 1989 Jun; 79(6):586-96. PubMed ID: 2475012
[TBL] [Abstract][Full Text] [Related]
5. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
Potter WZ; Scheinin M; Golden RN; Rudorfer MV; Cowdry RW; Calil HM; Ross RJ; Linnoila M
Arch Gen Psychiatry; 1985 Dec; 42(12):1171-7. PubMed ID: 2416297
[TBL] [Abstract][Full Text] [Related]
6. Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.
Nikisch G; Baumann P; Wiedemann G; Kiessling B; Weisser H; Hertel A; Yoshitake T; Kehr J; Mathé AA
J Clin Psychopharmacol; 2010 Oct; 30(5):496-503. PubMed ID: 20814316
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence.
Ogawa S; Tsuchimine S; Kunugi H
J Psychiatr Res; 2018 Oct; 105():137-146. PubMed ID: 30219563
[TBL] [Abstract][Full Text] [Related]
8. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
[TBL] [Abstract][Full Text] [Related]
9. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
Sher L; Oquendo MA; Li S; Huang YY; Grunebaum MF; Burke AK; Malone KM; Mann JJ
Neuropsychopharmacology; 2003 Sep; 28(9):1712-9. PubMed ID: 12825091
[TBL] [Abstract][Full Text] [Related]
10. Day/night variation of 5-hydroxyindole acetic acid concentration in rat cerebrospinal fluid after acute and long-term administration of a selective serotonin reuptake inhibitor, fluvoxamine.
Egashira T; Takayama F; Yamanaka Y; Takada K; Takeda H; Matsumiya T
Jpn J Pharmacol; 2000 Aug; 83(4):344-7. PubMed ID: 11001181
[TBL] [Abstract][Full Text] [Related]
11. A double-blind comparative clinical trial of citalopram vs maprotiline in hospitalized depressed patients.
Timmerman L; de Beurs P; Tan BK; Leijnse-Ybema H; Sanchez C; Høpfner Petersen HE; Cohen Stuart MH
Int Clin Psychopharmacol; 1987 Jul; 2(3):239-53. PubMed ID: 2447151
[TBL] [Abstract][Full Text] [Related]
12. Monoamine metabolites in cerebrospinal fluid of depressed patients during treatment with mianserin or amitriptyline.
Mendlewicz J; Pinder RM; Stulemeijer SM; Van Dorth R
J Affect Disord; 1982 Sep; 4(3):219-26. PubMed ID: 6182175
[TBL] [Abstract][Full Text] [Related]
13. Relationships of Cerebrospinal Fluid Monoamine Metabolite Levels With Clinical Variables in Major Depressive Disorder.
Yoon HS; Hattori K; Ogawa S; Sasayama D; Ota M; Teraishi T; Kunugi H
J Clin Psychiatry; 2017; 78(8):e947-e956. PubMed ID: 28749090
[TBL] [Abstract][Full Text] [Related]
14. Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid.
Bowden CL; Koslow SH; Hanin I; Maas JW; Davis JM; Robins E
Clin Pharmacol Ther; 1985 Mar; 37(3):316-24. PubMed ID: 2578912
[TBL] [Abstract][Full Text] [Related]
15. Spinal reflexes and the concentrations of 5-HIAA, MHPG, and HVA in lumbar cereborspinal fluid after spinal lesions in man.
Ashby P; Verrier M; Warsh JJ; Price KS
J Neurol Neurosurg Psychiatry; 1976 Dec; 39(12):1191-200. PubMed ID: 1011029
[TBL] [Abstract][Full Text] [Related]
16. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
Varela M; Alexiou GA; Liakopoulou M; Papakonstantinou E; Pitsouni D; Alevizopoulos GA
J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
[TBL] [Abstract][Full Text] [Related]
17. [Plasma levels of MHPG, HVA and total 5-HIAA in depression. Preliminary study].
Raucoules D; Levy C; Azorin JM; Bruno M; Valli M
Encephale; 1992; 18(6):611-6. PubMed ID: 1285270
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder.
Sher L; Carballo JJ; Grunebaum MF; Burke AK; Zalsman G; Huang YY; Mann JJ; Oquendo MA
Bipolar Disord; 2006 Oct; 8(5 Pt 2):543-50. PubMed ID: 17042827
[TBL] [Abstract][Full Text] [Related]
19. Effect of propranolol on monoamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia.
Scheinin M; van Kammen DP; Ninan PT; Linnoila M
Clin Pharmacol Ther; 1984 Jul; 36(1):33-9. PubMed ID: 6203678
[TBL] [Abstract][Full Text] [Related]
20. CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.
Molchan SE; Lawlor BA; Hill JL; Martinez RA; Davis CL; Mellow AM; Rubinow DR; Sunderland T
Biol Psychiatry; 1991 Jun; 29(11):1110-8. PubMed ID: 1714776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]